Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EXEL | Common Stock | Options Exercise | $229K | +11.7K | +5.46% | $19.57 | 226K | May 21, 2024 | Direct | F1 |
transaction | EXEL | Common Stock | Sale | -$245K | -11.7K | -5.18% | $20.96 | 214K | May 21, 2024 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EXEL | Option (right to buy) | Options Exercise | $0 | -11.7K | -100% | $0.00* | 0 | May 21, 2024 | Common Stock | 11.7K | $19.57 | Direct | F3 |
Id | Content |
---|---|
F1 | Includes 20,718 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. |
F2 | Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.95 to $20.99. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. |
F3 | The option, representing the right to purchase a total of 11,686 shares of Exelixis, Inc. common stock, became fully exercisable on May 25, 2017. |